| 001490 (2005) |
Silvia Mandel [Israël] ; Edna Grunblatt [Allemagne] ; Peter Riederer [Allemagne] ; Ninette Amariglio [Israël] ; Jasmine Jacob Hirsch [Israël] ; Gideon Rechavi [Israël] ; Moussa B. H. Youdim [Israël] | Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70 |
| 000E15 (2008) |
Masaki Wakamatsu [Japon] ; Shingo Iwata [Japon] ; Takeo Funakoshi [Japon] ; Makoto Yoshimoto [Japon] | Dopamine receptor agonists reverse behavioral abnormalities of α‐synuclein transgenic mouse, a new model of Parkinson's disease |
| 000F34 (2007) |
C. Warren Olanow [États-Unis] | The pathogenesis of cell death in Parkinson's disease – 2007 |
| 001128 (2007) |
Masaki Wakamatsu [Japon] ; Aiko Ishii [Japon] ; Yuriko Ukai [Japon] ; Junko Sakagami [Japon] ; Shingo Iwata [Japon] ; Mieko Ono [Japon] ; Kayo Matsumoto [Japon] ; Atsushi Nakamura [Japon] ; Norihiro Tada [Japon] ; Kazuto Kobayashi [Japon] ; Takeshi Iwatsubo [Japon] ; Makoto Yoshimoto [Japon] | Accumulation of phosphorylated α‐synuclein in dopaminergic neurons of transgenic mice that express human α‐synuclein |
| 000253 (2011) |
Glenda Halliday [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Matthew Stern [États-Unis] | Milestones in Parkinson's disease—Clinical and pathologic features |
| 000324 (2011) |
Anthony H. Schapira [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Etiology and pathogenesis of Parkinson's disease |
| 000512 (2010) |
Glenda Margaret Halliday [Australie] ; Heather Mccann [Australie] | The progression of pathology in Parkinson's disease |
| 000514 (2010) |
Kevin St. P. Mcnaught [États-Unis] ; Ruth Jnobaptiste [États-Unis] ; Tehone Jackson [États-Unis] ; Toni-Ann Jengelley [États-Unis] | The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease |
| 000576 (2010) |
Anna Martínez [Espagne] ; Manuel Portero-Otin [Espagne] ; Reinald Pamplona [Espagne] ; Isidre Ferrer [Espagne] | Protein Targets of Oxidative Damage in Human Neurodegenerative Diseases with Abnormal Protein Aggregates |
| 000931 (2009) |
Thibaud Lebouvier [France] ; Tanguy Chaumette [France] ; Sébastien Paillusson [France] ; Charles Duyckaerts [France] ; Stanislas Bruley Des Varannes [France] ; Michel Neunlist [France] ; Pascal Derkinderen [France] | The second brain and Parkinson’s disease |
| 000C47 (2008) |
M. E. Kalaitzakis [Royaume-Uni] ; M. B. Graeber [Royaume-Uni] ; S. M. Gentleman [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] | The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein staging |
| 000D87 (2008) |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Glial reactions in Parkinson's disease |
| 001158 (2006) |
A. Bloch [Suisse] ; A. Probst [Suisse] ; H. Bissig [Suisse] ; H. Adams [Suisse] ; M. Tolnay [Suisse] | α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects |
| 001210 (2006) |
Shin-Ichiro Kubo [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon] | Recessive Parkinson's disease |
| 001484 (2005) |
Guo-Hua Fan [République populaire de Chine] ; Chen Qi [République populaire de Chine] ; Sheng-Di Chen [République populaire de Chine] | Heat shock proteins reduce toxicity of 1‐methyl‐4‐phenylpyridinium ion in SK‐N‐SH cells |
| 001701 (2003) |
Kah Leong Lim ; Valina L. Dawson [États-Unis] ; Ted M. Dawson [États-Unis] | The Cast of Molecular Characters in Parkinson's Disease |
| 001849 (2002) |
Eliezer Masliah [États-Unis] ; Lawrence A. Hansen [États-Unis] ; Edward Rockenstein [États-Unis] ; Makoto Hashimoto [États-Unis] | Progress in the development of new treatments for combined Alzheimer's and Parkinson's diseases |
| 001880 (2002) |
David A. Grimes [Canada] ; J. David Grimes [Canada] ; Lem Racacho [Canada] ; Kylie A. Scoggan [Canada] ; Fabin Han [Canada] ; Betty Anne Schwarz [Canada] ; John Woulfe [Canada] ; Dennise Bulman [Canada] | Large French‐Canadian family with Lewy body parkinsonism: Exclusion of known loci |
| 001A43 (2001) |
Larry C. H. Park [États-Unis] ; David S. Albers [États-Unis] ; Hui Xu [États-Unis] ; J. Gordon Lindsay [Royaume-Uni] ; M. Flint Beal [États-Unis] ; Gary E. Gibson [États-Unis] | Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy |
| 001A61 (2001) |
Nadia Stefanova [Autriche, Bulgarie] ; Lars Klimaschewski [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] ; Markus Reindl [Autriche] | Glial cell death induced by overexpression of α‐synuclein |
| 000105 (2011) |
S. Orimo [Japon] ; T. Uchihara [Japon] ; T. Kanazawa [Japon] ; Y. Itoh [Japon] ; K. Wakabayashi ; A. Kakita [Japon] ; H. Takahashi [Japon] | Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson's disease |
| 000143 (2011) |
René Hernández- Vargas [Mexique] ; Luis Fonseca- Ornelas [Mexique] ; Ignacio L Pez- González [Mexique] ; Juan Riesgo- Escovar [Mexique] ; Mario Zurita [Mexique] ; Enrique Reynaud [Mexique] | Synphilin suppresses α‐synuclein neurotoxicity in a Parkinson's disease Drosophila model |
| 000168 (2011) |
R. Fekete [États-Unis] ; Joseph Jankovic [États-Unis] | Revisiting the relationship between essential tremor and Parkinson's disease |
| 000207 (2011) |
Michael J. Devine [Royaume-Uni] ; Katrina Gwinn [États-Unis] ; Andrew Singleton [États-Unis] ; John Hardy [Royaume-Uni] | Parkinson's disease and α‐synuclein expression |
| 000239 (2011) |
Davide Chiasserini [Italie] ; Alessandro Tozzi [Italie] ; Antonio De Iure [Italie] ; Michela Tantucci [Italie] ; Federica Susta [Italie] ; Pier Luigi Orvietani [Italie] ; Keizo Koya [États-Unis] ; Luciano Binaglia [Italie] ; Paolo Calabresi [Italie] | Mortalin inhibition in experimental Parkinson's disease |
| 000244 (2011) |
Tito Calì [Italie] ; Denis Ottolini [Italie] ; Marisa Brini [Italie] | Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease |
| 000274 (2011) |
S. Sharma [Royaume-Uni] ; R. Bandopadhyay ; T. Lashley ; A. E. M. Renton [Royaume-Uni] ; A. E. Kingsbury ; R. Kumaran ; C. Kallis ; C. Vilari O-Güell ; S. S. O'Sullivan ; Andrew Lees (neurologue) [Royaume-Uni] ; T. Revesz ; N. W. Wood ; J. L. Holton | LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study |
| 000303 (2011) |
Glenda M. Halliday [Australie] ; Claire H. Stevens [Australie] | Glia: Initiators and progressors of pathology in Parkinson's disease |
| 000318 (2011) |
Peter Jenner [Royaume-Uni] ; J. William Langston [États-Unis] | Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline |
| 000370 (2011) |
A. H. V. Schapira [Royaume-Uni] | Challenges to the development of disease‐modifying therapies in Parkinson’s disease |
| 000506 (2010) |
Ted M. Dawson [États-Unis] ; Valina L. Dawson [États-Unis] | The role of parkin in familial and sporadic Parkinson's disease |
| 000542 (2010) |
I. Mateo [Espagne] ; J. Infante [Espagne] ; P. Sánchez-Juan [Espagne] ; I. García-Gorostiaga [Espagne] ; E. Rodríguez-Rodríguez [Espagne] ; J. L. Vázquez-Higuera [Espagne] ; J. Berciano [Espagne] ; O. Combarros [Espagne] | Serum heme oxygenase‐1 levels are increased in Parkinson’s disease but not in Alzheimer’s disease |
| 000555 (2010) |
D. J. Bonda ; V. P. Baji ; B. Spremo-Potparevic [Serbie] ; G. Casadesus [États-Unis] ; X. Zhu ; M. A. Smith ; H. Lee | Review: Cell cycle aberrations and neurodegeneration |
| 000585 (2010) |
Raquel Duran [Espagne] ; Francisco J. Barrero [Espagne] ; Blas Morales [Espagne] ; Juan D. Luna [Espagne] ; Manuel Ramirez [Espagne] ; Francisco Vives [Espagne] | Plasma α‐synuclein in patients with Parkinson's disease with and without treatment |
| 000659 (2010) |
Yaping Chu [États-Unis] ; Jeffrey H. Kordower [États-Unis] | Lewy body pathology in fetal grafts |
| 000675 (2010) |
Charles H. Adler [États-Unis] ; Donald J. Connor [États-Unis] ; Joseph G. Hentz [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; John N. Caviness [États-Unis] ; Holly A. Shill [États-Unis] ; Brie Noble [États-Unis] ; Thomas G. Beach [États-Unis] | Incidental Lewy body disease: Clinical comparison to a control cohort |
| 000781 (2010) |
Jia-Yi Li [Suède] ; Elisabet Englund [Suède] ; H Kan Widner [Suède] ; Stig Rehncrona [Suède] ; Anders Björklund [Suède] ; Olle Lindvall [Suède] ; Patrik Brundin [Suède] | Characterization of Lewy body pathology in 12‐ and 16‐year‐old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease |
| 000799 (2010) |
Douglas C. Wallace [États-Unis] | Bioenergetics and the epigenome: Interface between the environment and genes in common diseases |
| 000801 (2010) |
Lena F. Burbulla [Allemagne] ; Guido Krebiehl [Allemagne] ; Rejko Krüger [Allemagne] | Balance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease |
| 000841 (2010) |
Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande] | A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease |
| 000A14 (2009) |
Hiroki Takeuchi [Japon] ; Takashi Yanagida [Japon] ; Masatoshi Inden [Japon] ; Kazuyuki Takata [Japon] ; Yoshihisa Kitamura [Japon] ; Kentaro Yamakawa [Japon] ; Hideyuki Sawada [Japon] ; Yasuhiko Izumi [Japon] ; Noriyuki Yamamoto [Japon] ; Takeshi Kihara [Japon] ; Kengo Uemura [Japon] ; Haruhisa Inoue [Japon] ; Takashi Taniguchi [Japon] ; Akinori Akaike [Japon] ; Ryosuke Takahashi [Japon] ; Shun Shimohama [Japon] | Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone‐induced Parkinson's disease models |
| 000A88 (2009) |
Christian Wider [États-Unis] ; Justus C. Dachsel [États-Unis] ; Alexandra I. Soto [États-Unis] ; Michael G. Heckman [États-Unis] ; Nancy N. Diehl [États-Unis] ; Mei Yue [États-Unis] ; Sarah Lincoln [États-Unis] ; Jan O. Aasly [Norvège] ; Kristoffer Haugarvoll [États-Unis, Norvège] ; John Q. Trojanowski [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Deborah Mash [États-Unis] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; J. Mark Gibson [Irlande (pays)] ; Timothy Lynch [Irlande (pays)] ; Dennis W. Dickson [États-Unis] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Matthew J. Farrer [États-Unis] ; Owen A. Ross [États-Unis] | FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expression |
| 000C22 (2008) |
Helene Plun-Favreau [Royaume-Uni] ; Sonia Gandhi [Royaume-Uni] ; Alison Wood-Kaczmar [Royaume-Uni] ; Emma Deas [Royaume-Uni] ; Zhi Yao [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] | What Have PINK1 and HtrA2 Genes Told Us about the Role of Mitochondria in Parkinson's Disease? |
| 000C78 (2008) |
Carola Schiesling ; Nicole Kieper ; Kay Seidel [Allemagne] ; Rejko Krüger | Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease |
| 000D21 (2008) |
Chun Zhou ; Yong Huang ; Serge Przedborski [États-Unis] | Oxidative Stress in Parkinson's Disease |
| 000D36 (2008) |
Maria G. Cersosimo [Argentine] ; Eduardo E. Benarroch [États-Unis] | Neural control of the gastrointestinal tract: Implications for Parkinson disease |
| 000D42 (2008) |
Claire Henchcliffe [États-Unis] ; Dikoma C. Shungu [États-Unis] ; Xiangling Mao [États-Unis] ; Chaorui Huang [États-Unis] ; Melissa J. Nirenberg [États-Unis] ; Bruce G. Jenkins [États-Unis] ; M. Flint Beal [États-Unis] | Multinuclear Magnetic Resonance Spectroscopy for in Vivo Assessment of Mitochondrial Dysfunction in Parkinson's Disease |
| 000D50 (2008) |
Ji-Young Park [Corée du Sud] ; Seung R. Paik [Corée du Sud] ; Ilo Jou [Corée du Sud] ; Sang Myun Park [Corée du Sud] | Microglial phagocytosis is enhanced by monomeric α‐synuclein, not aggregated α‐synuclein: Implications for Parkinson's disease |
| 000D77 (2008) |
Christopher F. Mcnicoll [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Frederick Wooten [États-Unis] ; Ray L. Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Anwar Ahmed [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Marie H. Saint-Hilaire [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Anita L. Destefano [États-Unis] ; Tammy Gillis [États-Unis] ; Jayalakshmi Mysore [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Ilia Itin [États-Unis] ; Irene Litvan [États-Unis] ; Garth Nicholson [Australie] ; Alastair Corbett [Australie] ; Martha Nance [États-Unis] ; Edward Drasby [États-Unis] ; Stuart Isaacson [États-Unis] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Peter P. Pramstaller [Italie] ; Jomana Al-Hinti [États-Unis] ; Anette T. Moller [Danemark] ; Karen Ostergaard [Danemark] ; Scott J. Sherman [États-Unis] ; Richard Roxburgh [Nouvelle-Zélande] ; Barry Snow [Nouvelle-Zélande] ; John T. Slevin [États-Unis] ; Franca Cambi [États-Unis] ; James F. Gusella [États-Unis] ; Richard H. Myers [États-Unis] | Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study |
| 000E51 (2008) |
Hiroshige Fujishiro [États-Unis] ; Roberta Frigerio [États-Unis] ; Melinda Burnett [États-Unis] ; Kevin J. Klos [États-Unis] ; Keith A. Josephs [États-Unis] ; Anthony Delledonne [États-Unis] ; Joseph E. Parisi [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Dennis W. Dickson [États-Unis] | Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease |
| 000E63 (2008) |
K. Wada-Isoe [Japon] ; K. Ohta [Japon] ; K. Imamura [Japon] ; M. Kitayama [Japon] ; T. Nomura [Japon] ; K. Yasui [Japon] ; K. Nakaso [Japon] ; K. Nakashima [Japon] | Assessment of hallucinations in Parkinson’s disease using a novel scale |
| 000F33 (2007) |
Charlene Hoffman Snyder [États-Unis] ; Charles H. Adler [États-Unis] | The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms |
| 000F40 (2007) |
Koichi Wakabayashi ; Kunikazu Tanji ; Fumiaki Mori ; Hitoshi Takahashi [Japon] | The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates |
| 000F46 (2007) |
Takeshi Iwatsubo [Japon] | THIS ARTICLE HAS BEEN RETRACTED: Pathological biochemistry of α‐synucleinopathy |
| 000F81 (2007) |
Elan D. Louis [États-Unis] ; Steven J. Frucht [États-Unis] | Prevalence of essential tremor in patients with Parkinson's disease vs. Parkinson‐plus syndromes |
| 001026 (2007) |
Osamu Yokota ; Kuniaki Tsuchiya ; Toshiki Uchihara ; Hiroshi Ujike ; Seishi Terada ; Mafuyu Takahashi ; Yuji Kimura ; Hideki Ishizu [Japon] ; Haruhiko Akiyama ; Shigetoshi Kuroda | Lewy body variant of Alzheimer’s disease or cerebral type Lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem |
| 001048 (2007) |
Anna Jelaso Langerveld [États-Unis] ; Daniel Mihalko [États-Unis] ; Cari Delong [États-Unis] ; Jeff Walburn [États-Unis] ; Charles F. Ide [États-Unis] | Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients |
| 001071 (2007) |
Soon S. Park [États-Unis] ; Emily M. Schulz [États-Unis] ; Daewoo Lee [États-Unis] | Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by α‐synuclein |
| 001198 (2006) |
Heiko Braak [Allemagne] ; Jürgen R. Bohl [Allemagne] ; Christian M. Müller [Allemagne] ; Udo Rüb [Allemagne] ; Rob A. I. De Vos [Pays-Bas] ; Kelly Del Tredici [Allemagne] | Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered |
| 001354 (2006) |
G. Webster Ross [États-Unis] ; Robert D. Abbott [États-Unis] ; Helen Petrovitch [États-Unis] ; Caroline M. Tanner [États-Unis] ; Daron G. Davis [États-Unis] ; James Nelson [États-Unis] ; William R. Markesbery [États-Unis] ; John Hardman [États-Unis] ; Kamal Masaki [États-Unis] ; Lenore Launer [États-Unis] ; Lon R. White [États-Unis] | Association of olfactory dysfunction with incidental Lewy bodies |
| 001388 (2005) |
Laura Parkkinen [Finlande] ; Tuula Pirttil [Finlande] ; Markku Tervahauta [Finlande] ; Irina Alafuzoff [Finlande] | Widespread and abundant α‐synuclein pathology in a neurologically unimpaired subject |
| 001437 (2005) |
Katsumi Tsuchiya [Japon] ; Hisao Tajima [Japon] ; Toyoyasu Kuwae [Japon] ; Takao Takeshima [Japon] ; Toshiya Nakano [Japon] ; Masaharu Tanaka [Japon] ; Katsuyoshi Sunaga [Japon] ; Yoko Fukuhara [Japon] ; Kenji Nakashima [Japon] ; Eisaku Ohama [Japon] ; Hideki Mochizuki [Japon] ; Yoshikuni Mizuno [Japon] ; Nobuo Katsube [Japon] ; Ryoichi Ishitani [Japon] | Pro‐apoptotic protein glyceraldehyde‐3‐phosphate dehydrogenase promotes the formation of Lewy body‐like inclusions |
| 001461 (2005) |
Naheed L. Khan ; Shushant Jain ; John M. Lynch ; Nicola Pavese ; Patrick Abou-Sleiman ; Janice L. Holton ; Daniel G. Healy ; William P. Gilks ; Mary G. Sweeney ; Milan Ganguly ; Vaneesha Gibbons ; Sonia Gandhi ; Jenny Vaughan ; Louise H. Eunson ; Regina Katzenschlager ; Juliet Gayton ; Graham Lennox ; Tamas Revesz ; David Nicholl [Royaume-Uni] ; Kailash P. Bhatia ; Niall Quinn ; David Brooks ; Andrew Lees (neurologue) [Royaume-Uni] ; Mary B. Davis ; Paola Piccini ; Andrew B. Singleton [États-Unis] ; Nicholas W. Wood | Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data |
| 001527 (2005) |
J. Eric Ahlskog [États-Unis] | Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease |
| 001667 (2004) |
V. Anantharam [États-Unis] ; M. Kitazawa [États-Unis] ; C. Latchoumycandane [États-Unis] ; A. Kanthasamy [États-Unis] ; A G Kanthasamy [États-Unis] | Blockade of PKCδ Proteolytic Activation by Loss of Function Mutants Rescues Mesencephalic Dopaminergic Neurons from Methylcyclopentadienyl Manganese Tricarbonyl (MMT)‐Induced Apoptotic Cell Death |
| 001761 (2003) |
Hideo Mori [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon] | Genotype–phenotype correlation: Familial Parkinson disease |
| 001769 (2003) |
M. Kurz ; G. Alves ; D. Aarsland [Norvège] ; J. P. Larsen | Familial Parkinson's disease: a community‐based study |
| 001806 (2003) |
Masayo Shamoto-Nagai [Japon] ; Wakako Maruyama [Japon] ; Yoji Kato [Japon] ; Ken-Ichi Isobe [Japon] ; Masashi Tanaka [Japon] ; Makoto Naoi [Japon] ; Toshihiko Osawa [Japon] | An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH‐SY5Y cells |
| 001942 (2002) |
Kevin St P. Mcnaught [États-Unis] ; P. Shashidharan [États-Unis] ; Daniel P. Perl [États-Unis] ; Peter Jenner [Royaume-Uni] ; C. Warren Olanow [États-Unis] | Aggresome‐related biogenesis of Lewy bodies |
| 001989 (2001) |
Yasushi Arai [Japon] ; Mineo Yamazaki [Japon] ; Osamu Mori [Japon] ; Hiromi Muramatsu [Japon] ; Goro Asano [Japon] ; Yasuo Katayama [Japon] | α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation |
| 001A08 (2001) |
Hitoshi Takahashi ; Koichi Wakabayashi [Japon] | The cellular pathology of Parkinson's disease |
| 001A44 (2001) |
M. Orth ; A. H. V. Schapira [Royaume-Uni] | Mitochondria and degenerative disorders |
| 001A95 (2001) |
S. Bostantjopoulou [Grèce] ; Z. Katsarou [Grèce] ; A. Papadimitriou [Grèce] ; V. Veletza [Grèce] ; G. Hatzigeorgiou [Grèce] ; A. Lees [Royaume-Uni] | Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation |
| 001B11 (2001) |
Subramianian Rajagopalan [États-Unis] ; Julie K. Andersen [États-Unis] | Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease? |
| 001B92 (2000) |
Yi Zhang ; Valina L. Dawson ; Ted M. Dawson | Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease |
| 001B98 (2000) |
John E. Duda [États-Unis] ; Virginia M. Lee [États-Unis] ; John Q. Trojanowski [États-Unis] | Neuropathology of synuclein aggregates |
| 001C20 (2000) |
Arpesh Mehta [États-Unis] ; Kyriaki Thermos [Grèce] ; Marie-Françoise Chesselet [États-Unis] | Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions |
| 001C43 (2000) |
George A. Veech [États-Unis] ; Jameel Dennis [États-Unis] ; Paula M. Keeney [États-Unis] ; Christopher P. Fall [États-Unis] ; Russell H. Swerdlow [États-Unis] ; W. Davis Parker Jr. [États-Unis] ; James P. Bennett Jr. [États-Unis] | Disrupted mitochondrial electron transport function increases expression of anti‐apoptotic Bcl‐2 and Bcl‐XL proteins in SH‐SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress |
| 001C47 (2000) |
G. Münch [Allemagne] ; H. J. Lüth [Allemagne] ; A. Wong [Allemagne] ; Th. Arendt [Allemagne] ; E. Hirsch [France] ; R. Ravid [Pays-Bas] ; P. Riederer [Allemagne] | Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation? |
| 001D64 (1999) |
Russell H. Swerdlow [États-Unis] ; W. Davis Parker Jr. [États-Unis] | Mitochondrial pathology in Parkinson's disease and implications for therapeutic intervention |
| 001E72 (1998) |
Manuel B. Graeber [Allemagne] ; Eva Grasbon-Frodl [Allemagne] ; Ulrich V. Eitzen [Allemagne] ; Siegfried Kösel [Allemagne] | Neurodegeneration and aging: Role of the second genome |
| 001E91 (1998) |
Nobutaka Hattori [Japon] ; Hiroyo Yoshino [Japon] ; Masashi Tanaka [Japon] ; Hiroshi Suzuki [Japon] ; Yoshikuni Mizuno [Japon] | Genotype in the 24-kDa Subunit Gene (NDUFV2) of Mitochondrial Complex I and Susceptibility to Parkinson Disease |
| 001F19 (1998) |
P. J. Blanchet [États-Unis] ; S. Konitsiotis [États-Unis] ; K. Hyland [États-Unis] ; L. A. Arnold [États-Unis] ; K. D. Pettigrew [États-Unis] ; T. N. Chase [États-Unis] | Chronic Exposure to MPTP as a Primate Model of Progressive Parkinsonism: A Pilot Study with a Free Radical Scavenger |
| 002023 (1997) |
Lutz M. Drach [Allemagne] ; Hans E. E. Steinmetz [Allemagne] ; Stefanie Wach [Allemagne] ; Jürgen Bohl [Allemagne] | HIGH PROPORTION OF DEMENTIA WITH LEWY BODIES IN THE POSTMORTEMS OF A MENTAL HOSPITAL IN GERMANY |
| 002358 (1995) |
John Hardy [États-Unis] | Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease |
| 002692 (1991) |
J. O. Rinne [Finlande] | Nigral degeneration in Parkinson's disease in relation to clinical features |
| 002694 (1991) |
J. S. Schneider [États-Unis] ; D. S. Rothblat [États-Unis] | Neurochemical evaluation of the striatum in symptomatic and recovered mptp-treated cats |
| 002770 (1990) |
Robert H. Perry ; Dorothy Irving ; Bernard E. Tomlinson | Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei |
